Have a personal or library account? Click to login
Addressing Failures in Achieving Hypertension Control in Low- and Middle-Income Settings through Simplified Treatment Algorithms Cover

Addressing Failures in Achieving Hypertension Control in Low- and Middle-Income Settings through Simplified Treatment Algorithms

Global Heart
Volume 17 (2022): Issue 1
By: Jennifer Cohn,  Helen Bygrave,  Teri Roberts,  Taskeen Khan,  Dike Ojji and  Pedro Ordunez  
Open Access
|Apr 2022

References

  1. 1Kontis V, Cobb LK, Mathers C, et al. Three Public Health Interventions Could Save 94 Million Lives in 25 Years. Circulation. 27 August 2019; 140(9): 715–725. Epub 10 June 2019. PMID: 31177824; PMCID: PMC6727958. DOI: 10.1161/CIRCULATIONAHA.118.038160
    Back to article
  2. 2Roth GA, Mensah GA, Johnson CO, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J Am Coll Cardio. 2020; 76: 2982–3021. DOI: 10.1016/j.jacc.2020.11.010
    Back to article
  3. 3Lawes CMM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008; 371: 1513–8. DOI: 10.1016/S0140-6736(08)60655-8
    Back to article
  4. 4Campbell NRC, Schutte AE, Varghese CV, et al. São Paulo call to action for the prevention and control of high blood pressure: 2020. J Clin Hypertens. 2019; 21: 1744–52. DOI: 10.1111/jch.13741
    Back to article
  5. 5Mills K, Bundy J, Kelly T, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-based Studies from 90 Countries. Circulation. 2016; 134: 441–50. DOI: 10.1161/CIRCULATIONAHA.115.018912
    Back to article
  6. 6Geldsetzer P, Manne-Goehler J, Marcus M-E, et al. The state of hypertension care in 44 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level data from 1·1 million adults. Lancet. 2019; 394: 652–62. DOI: 10.1016/S0140-6736(19)30955-9
    Back to article
  7. 7Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet. 2016; 387: 957–67. DOI: 10.1016/S0140-6736(15)01225-8
    Back to article
  8. 8Whelton PK, Carey RM, Aronow WS, et al. Clinical Practice Guideline 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A Report of the American College of Cardiology/Am. Hypertension. 2018; 71: e13–115. DOI: 10.1161/HYP.0000000000000065
    Back to article
  9. 9World Health Organization. Scaling up antiretroviral therapy in resource-limited settings: Guidelines for a public health approach. Geneva; 2002.
    Back to article
  10. 10World Health Organization. HEARTS Technical Package. https://www.who.int/cardiovascular_diseases/hearts/en/.
    Back to article
  11. 11Vedanthan R, Bernabe-Ortiz A, Herasme OI, et al. Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries. Cardiol Clin. 2017; 35: 99–115. DOI: 10.1016/j.ccl.2016.08.010
    Back to article
  12. 12Dzudie A, Rayner B, Ojji D, et al. Roadmap to achieve 25% hypertension control in Africa by 2025. Cardiovasc J Afr. 2017; 28: 262–73. DOI: 10.5830/CVJA-2017-040
    Back to article
  13. 13Cameron A, Ewen M, Ross-Degnan D, et al. Medicine prices, availability, and affordability in 36 developing and middle-income countries: A secondary analysis. Lancet. 2009; 373: 240–9. DOI: 10.1016/S0140-6736(08)61762-6
    Back to article
  14. 14Health Action International, World Health Organization. Medicine Prices, Availability, Affordability and Price Components, 2nd ed. 2008. http://www.haiweb.org/medicineprices/.
    Back to article
  15. 15Mendis S, Fukino K, Cameron A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Heal Organ. 2007; 85: 279–88. DOI: 10.2471/BLT.06.033647
    Back to article
  16. 16UN General Assembly. Political Declaration of the High-Level Meeting of the General Assembly on the Prevention and Control of Non-Communicable Diseases. A/RES/66/2. New York, NY; 2011.
    Back to article
  17. 17UN General Assembly. Political declaration of the 3rd High-Level Meeting of the General Assembly on the prevention and control of non-communicable diseases. A/RES/73/2. New York, NY; 2018. https://digitallibrary.un.org/record/1648984?ln=en.
    Back to article
  18. 18Cohn J, Kostova D, Moran AE, et al. Blood from a stone: Funding hypertension prevention, treatment, and care in low- and middle-income countries. J Hum Hypertens; 2021. DOI: 10.1038/s41371-021-00583-8
    Back to article
  19. 19World Health Organization. HEARTS Technical package for cardiovascular disease management in primary health care: Team-based care; 2018.
    Back to article
  20. 20Grimsrud A, Bygrave H, Doherty M, et al. Reimagining HIV service delivery: The role of differentiated care from prevention to suppression. J Int AIDS Soc. 2016; 19: 21484. DOI: 10.7448/IAS.19.1.21484
    Back to article
  21. 21Roberts DA, Tan N, Limaye N, et al. Cost of Differentiated HIV Antiretroviral Therapy Delivery Strategies in Sub-Saharan Africa: A Systematic Review. J Acquir Immune Defic Syndr. 2019; 82: S339–47. DOI: 10.1097/QAI.0000000000002195
    Back to article
  22. 22Gyamfi J, Plange-Rhule J, Iwelunmor J, et al. Training nurses in task-shifting strategies for the management and control of hypertension in Ghana: A mixed-methods study. BMC Health Serv Res. 2017; 17: 104. DOI: 10.1186/s12913-017-2026-5
    Back to article
  23. 23Anand TN, Joseph LM, Geetha AV, et al. Task sharing with non-physician health-care workers for management of blood pressure in low-income and middle-income countries: A systematic review and meta-analysis. Lancet Global Health. 2019; 7: e761–71. DOI: 10.1016/S2214-109X(19)30077-4
    Back to article
  24. 24Cobos Muñoz D, Merino Amador P, Monzon Llamas L, Martinez Hernandez D, Santos Sancho JM. Decentralization of health systems in low and middle income countries: A systematic review. Int J Public Health. 2017; 62: 219–29. DOI: 10.1007/s00038-016-0872-2
    Back to article
  25. 25Seidman G, Atun R. Human Resources for Health. 2017; 15: 29. DOI: 10.1186/s12960-017-0200-9
    Back to article
  26. 26Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): A prospective epidemiological survey. Lancet. 2011; 378: 1231–43. DOI: 10.1016/S0140-6736(11)61215-4
    Back to article
  27. 27Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. J Am Med Assoc. 2013; 310: 959–68. DOI: 10.1001/jama.2013.184182
    Back to article
  28. 28van der Linden EL, Agyemang C, van den Born BJH. Hypertension control in sub-Saharan Africa: Clinical inertia is another elephant in the room. J Clin Hypertens. 2020; 22: 959–61. DOI: 10.1111/jch.13874
    Back to article
  29. 29DiPette DJ, Goughnour K, Zuniga E, et al. Standardized treatment to improve hypertension control in primary health care: The HEARTS in the Americas Initiative. J Clin Hypertens. 2020; 22: 2285–95. DOI: 10.1111/jch.14072
    Back to article
  30. 30Waning B, Kyle M, Diedrichsen E, et al. Intervening in global markets to improve access to HIV/AIDS treatment: An analysis of international policies and the dynamics of global antiretroviral medicines markets. Glob Heal. 2010; 6: 9. DOI: 10.1186/1744-8603-6-9
    Back to article
  31. 31van Mourik MSM, Cameron A, Ewen M, et al. Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data. BMC Cardiovasc Disord. 2010; 10: 25. DOI: 10.1186/1471-2261-10-25
    Back to article
  32. 32Hu J, Mossialos E. Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts. Health Policy (New York). 2016; 120: 519–34. DOI: 10.1016/j.healthpol.2016.03.014
    Back to article
  33. 33Jaffe MG, Frieden TR, Campbell NRC, et al. Recommended treatment protocols to improve management of hypertension globally: A statement by resolve to save lives and the world hypertension league (WHL). J Clin Hypertens. 2018; 20: 829–36. DOI: 10.1111/jch.13280
    Back to article
  34. 34Bandak G, Sang Y, Gasparini A, et al. Hyperkalemia after initiating renin-angiotensin system blockade: The Stockholm Creatinine Measurements (SCREAM) project. J Am Hear Assoc. 2017; 6: e005428. DOI: 10.1161/JAHA.116.005428
    Back to article
  35. 35Franse LV, Pahor M, Di Bari M, et al. Hypokalemia associated with diuretic use and cardiovascular events in the systolic hypertension in the elderly program. Hypertension. 2000; 35: 1025–30. DOI: 10.1161/01.HYP.35.5.1025
    Back to article
  36. 36The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Am Med Assoc. 2002; 288: 2981–97. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12479763%5Cnhttp://jama.jamanetwork.com/article.aspx?articleid=195626. DOI: 10.1001/jama.288.23.2981
    Back to article
  37. 37Ojji DB, Mayosi B, Francis V, et al. Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans. N Engl J Med. 2019; 380: 2429–39. DOI: 10.1056/NEJMoa1901113
    Back to article
  38. 38World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach – 2nd ed. Geneva; 2016.
    Back to article
  39. 39Heizhati M, Shi Q, Li N, et al. Introduction of simple standard treatment algorithm could improve hypertension control in primary health care of rural Xinjiang in 17 years period. J Hypertens. 2018; 36: e35–6. DOI: 10.1097/01.hjh.0000548131.77220.09
    Back to article
  40. 40UNAIDS. AIDS Info. Retrieved from https://aidsinfo.unaids.org. (accessed 19 October 2021).
    Back to article
  41. 41Keiser O, Orrell C, Egger M, et al. Public-health and individual approaches to antiretroviral therapy: Township South Africa and Switzerland compared. PLoS Med. 2008; 5(7): e148. DOI: 10.1371/journal.pmed.0050148
    Back to article
  42. 42Long L, Kuchukhidze S, Pascoe S, et al. Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub-Saharan Africa: A rapid systematic review. J Int AIDS Soc. 2020; 23: e25640. DOI: 10.1002/jia2.25640
    Back to article
  43. 43Jeemon P, et al. World Heart Federation Roadmap for Hypertension – A 2021 Update. Global Heart. 2021; 16(1): 63. DOI: 10.5334/gh.1066
    Back to article
  44. 44Alamo ST, Wagner GJ, Ouma J, et al. Strategies for Optimizing Clinic Efficiency in a Community- Based Antiretroviral Treatment Programme in Uganda. AIDS Behav. 2013; 17. DOI: 10.1007/s10461-012-0199-9
    Back to article
  45. 45Jakubowski A, Kabami J, Mwai D, et al. Provision of streamlined HIV care associated with reduced economic burden of care-seeking among HIV-infected adults. In 21st International AIDS Conference. Durban; 2016.
    Back to article
  46. 46Christ B, Dijk JH Van, Ballif M, et al. Differentiated antiretroviral therapy delivery in rural Zimbabwe. Availability, needs and challenges. Preprint Published Online First; 2020. DOI: 10.31219/osf.io/zpq2e
    Back to article
  47. 47Salam A, Kanukula R, Atkins E, et al. Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: A systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2019; 37: 1768–74. DOI: 10.1097/HJH.0000000000002096
    Back to article
  48. 48Nugent R, Bertram MY, Jan S, et al. Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals. Lancet. 2018; 391: 2029–35. DOI: 10.1016/S0140-6736(18)30667-6
    Back to article
DOI: https://doi.org/10.5334/gh.1082 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: May 24, 2021
Accepted on: Oct 29, 2021
Published on: Apr 12, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
hypertension,
treatment,
health policy

© 2022 Jennifer Cohn, Helen Bygrave, Teri Roberts, Taskeen Khan, Dike Ojji, Pedro Ordunez, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 17 (2022): Issue 1Next article